Abstract
Hypertension after kidney transplant is a frequent occurrence in pediatric patients. It is a risk factor for graft loss and contributes to the significant burden of cardiovascular disease (CVD) in this population. The etiology of posttransplant hypertension is multifactorial including donor factors, recipient factors, medications, and lifestyle factors similar to those prevalent in the general population. Ambulatory blood pressure monitoring has emerged as the most reliable method for measuring hypertension in pediatric transplant recipients, and many consider it to be essential in the care of these patients. Recent technological advances including measurement of carotid intima-media thickness, pulse wave velocity, and myocardial strain using specked echocardiography and cardiac magnetic resonance imaging have improved our ability to assess CVD burden. Since hypertension remains underrecognized and inadequately treated, an early diagnosis and an appropriate control should be the focus of therapy to help improve patient and graft survival.
Highlights
Olga Charnaya and Asha Moudgil*Division of Pediatric Nephrology, Children’s National Health System, Washington, DC, USA
Hypertension after renal transplantation is a common phenomenon with an estimated prevalence of 70–90% in adults and 58–89% in children [1,2,3]
left ventricular hypertrophy (LVH) is prevalent in approximately 50% of patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) and in kidney transplant recipients
Summary
Division of Pediatric Nephrology, Children’s National Health System, Washington, DC, USA. Hypertension in the Pediatric Kidney Transplant Recipient. Hypertension after kidney transplant is a frequent occurrence in pediatric patients. It is a risk factor for graft loss and contributes to the significant burden of cardiovascular disease (CVD) in this population. The etiology of posttransplant hypertension is multifactorial including donor factors, recipient factors, medications, and lifestyle factors similar to those prevalent in the general population. Ambulatory blood pressure monitoring has emerged as the most reliable method for measuring hypertension in pediatric transplant recipients, and many consider it to be essential in the care of these patients. Recent technological advances including measurement of carotid intima-media thickness, pulse wave velocity, and myocardial strain using specked echocardiography and cardiac magnetic resonance imaging have improved our ability to assess CVD burden.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have